Case Study: Merck Sharp & Dohme saves over three million vaccine doses with TransVoyant

MSD saves 3 million vaccine doses with TransVoyant

Merck Sharp & Dohme (MSD) operated a complex global pharmaceutical supply chain reliant on disparate partners and fragmented systems, making it impossible to trace performance or diagnose issues in real time. This vulnerability threatened the integrity of life-saving vaccines and oncology treatments during transit. To address this, MSD partnered with vendor TransVoyant to deploy its Continuous Decision Intelligence (CDI™) platform and create a predictive, plant-to-patient control tower.

The TransVoyant solution fused data from ERP systems, partner clouds, and IoT devices into a single source of truth. The platform mathematically calculated real-time location, product stability, and thermal exposure to predict and trigger automated interventions. This predictive defense saved over three million vaccine doses from thermal destruction, securing the supply of critical medicines for patients.

Merck Sharp & Dohme (msd)